183 related articles for article (PubMed ID: 25569716)
1. Conversion of the LIMA1 tumour suppressor into an oncogenic LMO-like protein by API2-MALT1 in MALT lymphoma.
Nie Z; Du MQ; McAllister-Lucas LM; Lucas PC; Bailey NG; Hogaboam CM; Lim MS; Elenitoba-Johnson KS
Nat Commun; 2015 Jan; 6():5908. PubMed ID: 25569716
[TBL] [Abstract][Full Text] [Related]
2. Stability and subcellular localization of API2-MALT1 chimeric protein involved in t(11;18) (q21;q21) MALT lymphoma.
Izumiyama K; Nakagawa M; Yonezumi M; Kasugai Y; Suzuki R; Suzuki H; Tsuzuki S; Hosokawa Y; Asaka M; Seto M
Oncogene; 2003 Nov; 22(50):8085-92. PubMed ID: 14603249
[TBL] [Abstract][Full Text] [Related]
3. [Prevalence of API2-MALT1 fusion gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas and diffuse large B cell lymphomas].
Li BZ; Lu HF; Sheng WQ; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):765-8. PubMed ID: 20079017
[TBL] [Abstract][Full Text] [Related]
4. API2-MALT1 fusion gene in colorectal lymphoma.
Sakugawa ST; Yoshino T; Nakamura S; Inagaki H; Sadahira Y; Nakamine H; Okabe M; Ichimura K; Tanimoto M; Akagi T
Mod Pathol; 2003 Dec; 16(12):1232-41. PubMed ID: 14681324
[TBL] [Abstract][Full Text] [Related]
5. Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
Hosokawa Y
Apoptosis; 2005 Jan; 10(1):25-34. PubMed ID: 15711920
[TBL] [Abstract][Full Text] [Related]
6. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma.
Hosokawa Y; Suzuki H; Suzuki Y; Takahashi R; Seto M
Cancer Res; 2004 May; 64(10):3452-7. PubMed ID: 15150097
[TBL] [Abstract][Full Text] [Related]
7. Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination.
Baens M; Fevery S; Sagaert X; Noels H; Hagens S; Broeckx V; Billiau AD; De Wolf-Peeters C; Marynen P
Cancer Res; 2006 May; 66(10):5270-7. PubMed ID: 16707452
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of MALT lymphoma: two signaling pathways underlying the antiapoptotic effect of API2-MALT1 fusion protein.
Nakagawa M; Seto M; Hosokawa Y
Leukemia; 2006 Jun; 20(6):929-36. PubMed ID: 16572204
[TBL] [Abstract][Full Text] [Related]
9. API2-MALT1 oncoprotein promotes lymphomagenesis via unique program of substrate ubiquitination and proteolysis.
Rosebeck S; Lim MS; Elenitoba-Johnson KS; McAllister-Lucas LM; Lucas PC
World J Biol Chem; 2016 Feb; 7(1):128-37. PubMed ID: 26981201
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous copy numbers of API2-MALT1 chimeric transcripts in mucosa-associated lymphoid tissue lymphoma.
Suguro-Katayama M; Suzuki R; Kasugai Y; Nakamura T; Suzuki H; Hosokawa Y; Shiku H; Nakamura S; Seto M
Leukemia; 2003 Dec; 17(12):2508-12. PubMed ID: 14562112
[TBL] [Abstract][Full Text] [Related]
11. The API2/MALT1 fusion product may lead to germinal center B cell lymphomas by suppression of apoptosis.
Stoffel A; Le Beau MM
Hum Hered; 2001; 51(1-2):1-7. PubMed ID: 11096264
[TBL] [Abstract][Full Text] [Related]
12. Auto-ubiquitination-induced degradation of MALT1-API2 prevents BCL10 destabilization in t(11;18)(q21;q21)-positive MALT lymphoma.
Noels H; Somers R; Liu H; Ye H; Du MQ; De Wolf-Peeters C; Marynen P; Baens M
PLoS One; 2009; 4(3):e4822. PubMed ID: 19279678
[TBL] [Abstract][Full Text] [Related]
13. API2-MALT1 fusion defines a distinctive clinicopathologic subtype in pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue.
Okabe M; Inagaki H; Ohshima K; Yoshino T; Li C; Eimoto T; Ueda R; Nakamura S
Am J Pathol; 2003 Apr; 162(4):1113-22. PubMed ID: 12651604
[TBL] [Abstract][Full Text] [Related]
14. Gastric low-grade B-cell MALT lymphoma: treatment, response, and genetic alteration.
Nakamura T; Inagaki H; Seto M; Nakamura S
J Gastroenterol; 2003; 38(10):921-9. PubMed ID: 14614598
[TBL] [Abstract][Full Text] [Related]
15. [The frequency of API2-MALT1 fusion gene variants in MALT lymphoma and its correlation with apoptosis of MALT lymphoma].
Yang WX; Li GD; Zhou Q; Liu WP; Chen N; Gong J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):35-9. PubMed ID: 15696476
[TBL] [Abstract][Full Text] [Related]
16. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
17. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma development and treatment.
Rosebeck S; Lucas PC; McAllister-Lucas LM
Future Oncol; 2011 May; 7(5):613-7. PubMed ID: 21568677
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
Nakamura T; Seto M; Tajika M; Kawai H; Yokoi T; Yatabe Y; Nakamura S
Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851
[TBL] [Abstract][Full Text] [Related]
19. The t(14;18)(q32;q21)/IGH-MALT1 translocation in gastrointestinal extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Zhang S; Wei M; Liang Q; Johnson D; Dow N; Nelson A; Aguilera N; Auerbach A; Wang G
Histopathology; 2014 May; 64(6):791-8. PubMed ID: 24236896
[TBL] [Abstract][Full Text] [Related]
20. Oncogene-induced MALT1 protease activity drives posttranscriptional gene expression in malignant lymphomas.
Wimberger N; Ober F; Avar G; Grau M; Xu W; Lenz G; Menden MP; Krappmann D
Blood; 2023 Dec; 142(23):1985-2001. PubMed ID: 37623434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]